Noble Financial Remains a Buy on MAIA Biotechnology, Inc. (MAIA)
In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on MAIA Biotechnology, Inc. (MAIA – Research Report), ...
Health Care Up as Vaccine Makers Surge -- Health Care Roundup
Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.
MAIA Biotechnology Shares Rise After Supply Agreement With BeiGene
MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.
MAIA Biotechnology enters clinical supply agreement with BeiGene for THIO
MAIA Biotechnology (MAIA) announced that it has entered into a clinical supply agreement with BeiGene (BGNE) to assess the efficacy of THIO, ...
Le Lézard2d
F5 to Report First Quarter Fiscal Year 2025 Financial Results
F5, Inc. announced it will report its first quarter fiscal year 2025 financial results on Tuesday, January 28, 2025 following the market close. F5 also will host a live webcast to discuss its results ...
MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications
MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications ...